Lungscreen
Lungscreen is a Queensland-based lung screening services and imaging technology provider that delivers ILO-standard occupational screening, National Lung Cancer Screening Program reporting, and lung nodule management through its Radar platform and Azure-hosted Vendor Neutral Archive for radiology providers, employers, and government.
- Company typePrivate
- Founded-
- HeadquartersBuderim, Australia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Lungscreen does
Lungscreen (legal entity Lung Screen Australia Pty Ltd) is a privately held Australian lung screening services and imaging technology provider founded in 2016 and headquartered in Buderim, Queensland. The company operates across three service lines: occupational lung disease screening for Queensland coal, mineral mine, and quarry workers (where it is the sole government-appointed provider of dual-read ILO screening under the Coal Mine Workers' Health Scheme), participation in the federal National Lung Cancer Screening Program as a reporting platform provider, and a Virtual Lung Nodule Clinic offering nationwide incidental nodule surveillance.
The technology stack centres on two proprietary assets: Radar, a bespoke cloud-based radiologist reporting platform with standardised templates, double-reading workflows, and adjudication; and a Vendor Neutral Archive hosted on Australian Microsoft Azure infrastructure. AI capabilities augment CT and chest X-ray interpretation through nodule detection and characterisation, incidental finding flagging, and AI-assisted structured report generation. The platform is integrated with Telstra Health for automated submission of synoptic reports to the national lung cancer screening registry, and the radiologist network is benchmarked against the University of Illinois at Chicago.
Lungscreen makes money primarily through fee-per-assessment occupational screening billed to employers, workers, and radiology clinics under published schedules, supplemented by recurring service contracts with radiology provider partners (Lumus Imaging, PRP Imaging, Carlisle Health, Radiology SA, Imaging Associates) who use Lungscreen as their NLCSP reporting layer, and by professional services revenue from the Virtual Lung Nodule Clinic. The company is privately held, bootstrapped, and led by Dr Siavash Es'haghi (Managing Director/CEO) with approximately 10 employees including 10 subspecialist chest radiologists.
Lungscreen firmographics
Firmographics- Name
- Lungscreen
- Legal name
- Lung Screen Australia Pty Ltd
- Website
- https://lungscreen.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Lungscreen is a Queensland-based lung screening services and imaging technology provider that delivers ILO-standard occupational screening, National Lung Cancer Screening Program reporting, and lung nodule management through its Radar platform and Azure-hosted Vendor Neutral Archive for radiology providers, employers, and government.
- Ownership category
- akta.pro rank
Lungscreen industry classification
Industry- Product category
- Lung Screening Services
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Lung Cancer Screening & Pulmonary Nodule Clinic (HLAKANAI)
- akta.pro secondary industries
- Occupational & Environmental Lung Disease Clinic (HLAKANAN), Thoracic (Lung) Oncology (HLAKAFAL), Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry) (HLAFAKAJ)
Keywords
Where Lungscreen is headquartered
LocationHeadquarters
- HQ city
- Buderim
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Lungscreen business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Government-Commissioned Screening Services: Lungscreen is the sole appointed provider by the Queensland Government to deliver dual-read ILO screening under the Coal Mine Workers' Health Scheme. Revenue is derived from legislated health assessments that coal and quarry mine workers are required to undergo at least every 5 years, before employment, and at retirement.
- Fee-for-Service Occupational Lung Disease Screening: Chest X-ray ILO reporting, spirometry coordination, and dual-reading services are billed per worker per assessment. Pricing schedules are publicly available (Schedule of Fees). Services cover coal mine workers, mineral mine, and quarry workers under Queensland regulations.
- National Lung Cancer Screening Program (NLCSP) Services: Lung cancer screening services including LDCT scans, AI-driven reporting, synoptic report generation, and Telstra Health registry integration, provided to radiology providers and GP practices participating in the national program.
- Lung Nodule Management Services: Virtual Lung Nodule Clinic providing specialist clinical review, coordinated follow-up, and surveillance services for incidental pulmonary nodules across Australia, supporting both patients and referring clinicians.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Occupational Lung Disease Screening - Per Worker Assessment |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Lungscreen product offering
Product offeringCore offering
Lungscreen delivers lung screening and diagnostic imaging services covering occupational lung disease screening for mine and quarry workers, low-dose CT lung cancer screening under the National Lung Cancer Screening Program (NLCSP), and virtual lung nodule management. The company operates a proprietary cloud-based reporting platform (Radar), a Vendor Neutral Archive (VNA) on Australian-hosted Microsoft Azure, and AI-driven image analysis, with dual-read ILO-standard reporting performed by NIOSH-accredited B-Reader radiologists.
Product overview
Lungscreen is a lung screening technology platform consisting of three core service areas: Occupational Lung Disease Screening (covering Coal Mine Workers' Health Scheme and Mining & Quarrying programs), Lung Cancer Screening (National Lung Cancer Screening Program), and Lung Nodule Management. The platform is powered by two proprietary technology systems: Radar, a cloud-based reporting software for radiologists with double-reporting and adjudication workflows, and a Vendor Neutral Archive (VNA) for secure image storage. AI capabilities augment nodule detection, characterisation, and report generation across all screening services.
Differentiator
Problem solved
Functional benefit
Brands
- Radar: Bespoke cloud-based reporting software for radiologists, designed to streamline and standardise the reporting process for occupational health.
- VNA (Vendor Neutral Archive)
Quantifiable outcome
- Lungscreen is the only organisation appointed by the Queensland Government to deliver dual-read ILO screening under the Coal Mine Workers' Health Scheme
- +3 more outcomes
Companies that use Lungscreen
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles5 records
Lungscreen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature7 records
Lungscreen partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- University of Illinois at Chicago (UIC)coreLungscreen participates in an international auditing program with UIC, a recognised authority in ILO reporting. This benchmarking partnership ensures Lungscreen's processes and radiologist reporting meet global best practices and maintains high standards of diagnostic accuracy in lung health.
- Telstra HealthcoreLungscreen's reporting platform is integrated with Telstra Health for the National Lung Cancer Screening Program, enabling automated submission of structured, synoptic reports with detailed nodule data, Lung-RADS scores, patient demographics, and smoking history to the national registry.
- Lumus ImagingcoreLumus Imaging is a radiology provider partner that uses Lungscreen's AI-enabled lung cancer screening platform and compliant synoptic reporting infrastructure. Their clinics perform CT scans and leverage Lungscreen's integrated reporting platform.
- PRP ImagingcorePRP Imaging is a radiology provider partner using Lungscreen's reporting platform and nodule management services for lung screening and occupational lung disease assessments.
- Carlisle HealthminorCarlisle Health is a radiology provider partner for lung cancer screening and occupational lung disease services using Lungscreen's platform.
- Radiology SAminorRadiology SA is a radiology provider partner using Lungscreen's platform for lung screening services.
- Imaging AssociatesminorImaging Associates is a radiology provider partner for lung cancer screening program services using Lungscreen's platform.
- Resources Safety and Health Queensland (RSHQ)coreRSHQ is a Queensland government body regulating mining safety. Lungscreen is the sole appointed provider of dual-read ILO screening services under the Coal Mine Workers' Health Scheme, a legislated program protecting respiratory health of workers in Queensland's coal mining industry.
- Microsoft AzurecoreLungscreen's VNA is hosted on Microsoft Azure servers located in Australia. Azure is endorsed by the Australian Federal Government due to its security protocols, ensuring all patient data is secure in line with Australia's privacy policies.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Lungscreen competitors and assessment
Company assessmentBroad incumbents
- Sonic HealthPlus: Australia's largest occupational health provider delivering pre-employment and periodic health assessments across industries including mining. Comparable to Lungscreen as an occupational screening provider to Queensland mining workers, with similar employer-led channels and health assessment workflow orientation.
- Capitol Health: ASX-listed Australian diagnostic imaging network providing radiology services across multiple states. Comparable to Lungscreen as a clinical imaging provider for lung cancer screening and adjacent diagnostic workflows, though diversified across all modalities rather than lung-specialised.
- I-MED Radiology Network: Australia's largest radiology provider, operating hundreds of clinics across the country. Directly comparable to Lungscreen as a clinical imaging provider for lung cancer screening under NLCSP and adjacent occupational imaging, though it operates across all modalities rather than specialising in lung screening.
- Lunit: Korean-listed medical imaging AI company with FDA-cleared lung nodule detection and breast cancer AI products (post-Volpara acquisition). Comparable in lung cancer and imaging AI modality, and increasingly relevant as NLCSP and similar screening programs worldwide standardise AI-augmented reporting workflows.
- Aspen Medical: Australian-headquartered occupational and remote health services provider with established mining and industrial health screening offerings. Comparable to Lungscreen's occupational lung disease screening segment for mining and industrial workforces, particularly in Queensland and regional Australia.
Emerging players
- Optellum: AI-driven lung cancer screening platform for pulmonary nodule management and Lung-RADS decision support. Comparable to Lungscreen's AI nodule detection and lung cancer screening capabilities, though Optellum is an AI software provider rather than a full-service screening operator.
- Riverain Technologies: US-based AI imaging company specialising in chest X-ray and CT interpretation, including ClearRead and LungPlot products. Direct technology peer to Lungscreen in AI-driven nodule detection and chest X-ray reporting augmentation.
- Annalise.ai: Australian-headquartered comprehensive radiology AI platform covering chest X-ray and CT findings, including lung-related pathologies. Direct technology overlap with Lungscreen's AI imaging and report-generation stack, and is an Australian-based peer competing for similar radiology-provider AI deployments.
Direct peers
- Lumus Imaging: Australian radiology provider and named Lungscreen channel partner using its AI-enabled lung cancer screening platform. Operates many of the same chest X-ray and CT imaging clinics Lungscreen relies on for scanning delivery, making it both a partner and a potential in-house competitor for primary lung screening reporting.
Regional players
- Queensland X-Ray: Major Queensland-headquartered diagnostic imaging provider operating across multiple modalities. Comparable to Lungscreen as a regional radiology network in Queensland with potential overlap in lung CT, NLCSP, and occupational chest imaging volumes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lungscreen social profiles
Digital presenceLungscreen compliance and trust
Trust signalCompliance2 records
Lungscreen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lungscreen leadership team
Management profileNumber of profiles
Profiles11 records
Lungscreen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lungscreen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lungscreen
What does Lungscreen do?
Lungscreen delivers lung screening and diagnostic imaging services covering occupational lung disease screening for mine and quarry workers, low-dose CT lung cancer screening under the National Lung Cancer Screening Program (NLCSP), and virtual lung nodule management. The company operates a proprietary cloud-based reporting platform (Radar), a Vendor Neutral Archive (VNA) on Australian-hosted Microsoft Azure, and AI-driven image analysis, with dual-read ILO-standard reporting performed by NIOSH-accredited B-Reader radiologists.
Is Lungscreen a public or private company?
Lungscreen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lungscreen founded?
Lungscreen was founded in -1. It employs 1 to 10 people.
Where is Lungscreen based?
Lungscreen is headquartered in Buderim, Australia, in the Oceania region.
How does Lungscreen make money?
Four revenue lines are on record. Government-Commissioned Screening Services are the primary driver. The others are fee-for-Service Occupational Lung Disease Screening, national Lung Cancer Screening Program (NLCSP) Services and lung Nodule Management Services.
Who are Lungscreen's main competitors?
Broad incumbents on record are Sonic HealthPlus, Capitol Health, I-MED Radiology Network, Lunit and Aspen Medical. Emerging players are Optellum, Riverain Technologies and Annalise.ai. Lumus Imaging is listed as a direct peer. Queensland X-Ray is listed as a regional player.
Does Lungscreen have an API?
No public API is recorded for Lungscreen.
What industry is Lungscreen in?
Lungscreen's product category is Lung Screening Services. Its primary akta.pro industry code is HLAKANAI, Lung Cancer Screening & Pulmonary Nodule Clinic, with a secondary code of HLAKANAN, Occupational & Environmental Lung Disease Clinic. Its NAICS code is 621512 and its SIC code is 8071.